... high volume move once the stock breaks through this level as traders are watching this stock closely. Stay tuned. ( click to enlarge ) Exelixis, …
CHICAGO, Jan. 12, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BBT, EXEL, …
Covered Call
Exelixis Inc. (NASDAQ:EXEL) Director George A. Scangos sold 204,894 shares of the firm’s stock in a transaction dated Wednesday, December 7th. The stock was sold at an average price of $17.81, for a total …
Sells
Exelixis, Inc. (EXEL) opened the session with a $18.33 price tag, later ranging from $17.76 to $18.44, the range at which the stock has traded at throughout the day. The stock of Tenet Healthcare Corp (NYSE:THC) earned …
Tenet Healthcare Corporation
Exelixis is having an incredibly strong day in the market today after reporting positive news from a key Phase 2 clinical trial. Today, we'll talk about the data that was released, how the stock reacted to the news, and what …
Soaring
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Exelixis Inc (NASD: EXEL) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low …
One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. Exelixis has an average rating of “Buy” and an average target price of $14.93. Shares of Exelixis …
Middle East
Shares of Exelixis Inc. (EXEL) were up +0.39 or +8.37 percent in Tuesday’s premarket after the company announced that the FDA had approved the company’s lead cancer drug cabozanitinib, which will be marketed …
Exelixis, Inc. (EXEL - Free Report) is scheduled to report third-quarter 2016 results on Nov 3 after the market closes. Exelixis had a mixed track record over the last four quarters. The company surpassed expectations …
ZACKS2mon